{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:25:20Z","timestamp":1790958320837,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clinimag.2021.05.025","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T11:55:35Z","timestamp":1622462135000},"page":"276-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Diagnostic approach in multiple sclerosis with MRI: an update"],"prefix":"10.1016","volume":"78","author":[{"given":"Stefan","family":"Weidauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Raab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Hattingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2021.05.025_bb0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis. The 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nic.2016.12.002","article-title":"Brain and spinal cord MR imaging features in multiple sclerosis and variants","volume":"27","author":"Dekker","year":"2017","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/B978-0-444-52001-2.00002-9","article-title":"Pathology of multiple sclerosis and related inflammatory demyelinating diseases","volume":"122","author":"Kutzelnigg","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transec-tion in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1474-4422(18)30451-4","article-title":"Association between pathological and MRI findings in multiple sclerosis: an update","volume":"18","author":"Filippi","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0050","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jamaneurol.2019.2478","article-title":"Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis","volume":"76","author":"Sinnecker","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0055","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00330-013-3080-y","article-title":"Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla","volume":"24","author":"Kilsdonk","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11940-017-0454-5","article-title":"Defining disease activity and response to therapy in MS","volume":"19","author":"Kaunzner","year":"2017","journal-title":"Curr Treat Opin Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0065","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ana.25808","article-title":"Identifying progression in multiple scle-rosis: new perspectives","volume":"88","author":"Filippi","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/1352458520910496","article-title":"Challenges in multiple sclerosis diagnosis: misunderstanding and misapplication of the McDonald criteria","volume":"27","author":"Solomon","year":"2021","journal-title":"Mult Scler J"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.0000000000006583","article-title":"Misdiagnosis of multiple sclerosis. Impact of the 2017 McDonald criteria on clinical practice","volume":"92","author":"Solomon","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0080","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1474-4422(16)30043-6","article-title":"Atypical inflammatory demyelinating syndroms of the CNS","volume":"15","author":"Hardy","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0085","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult Scler"},{"issue":"Suppl. 2","key":"10.1016\/j.clinimag.2021.05.025_bb0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00062-015-0430-y","article-title":"MRI in the diagnosis and monitoring of multiple sclerosis: an update","volume":"25","author":"Wattjes","year":"2015","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0095","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3174\/ajnr.A4539","article-title":"Revised recommendations of the con-sortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis","volume":"37","author":"Traboulsee","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0100","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/brain\/awz144","article-title":"Assessment of lesions on magnetic reso-nance imaging in multiple sclerosis: practical guidelines","volume":"142","author":"Filippi","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrneurol.2015.106","article-title":"MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis\u2014clinical implementation in the diagnostic process","volume":"11","author":"Rovira","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrneurol.2015.157","article-title":"MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis\u2014establishing disease prognosis and monitoring patients","volume":"11","author":"Wattjes","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286419859722","article-title":"Advances in brain imaging in multiple sclerosis","volume":"12","author":"Cortese","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(20)30432-4","article-title":"Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care","volume":"20","author":"Fadda","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0125","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00247-019-04582-3","article-title":"Pediatric multiple sclerosis: from clinical basis to imaging spectrum and differential diagnosis","volume":"41","author":"Padilha","year":"2020","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0130","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ana.25802","article-title":"Progressive multiple sclerosis","volume":"88","author":"Khoury","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0135","first-page":"572","article-title":"Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology","volume":"26","author":"Geurts","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnen\/62.7.723","article-title":"Subpial demyelination in the cerebral cortex of multiple sclerosis patients","volume":"62","author":"B\u00f8","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/brain\/122.1.17","article-title":"Cortical lesions in multiple sclerosis","volume":"122","author":"Kidd","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00062-017-0604-x","article-title":"Magnetic resonance imaging and clinical features in acute and subacute myelopathies","volume":"27","author":"Weidauer","year":"2017","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","article-title":"Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis","volume":"85","author":"Absinta","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0160","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","article-title":"Association of chronic active multiple scle-rosis lesions with disability in vivo","volume":"76","author":"Absinta","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0165","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/brain\/awz156","article-title":"Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis","volume":"142","author":"Brownlee","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0170","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3174\/ajnr.A2975","article-title":"Reduced diffusion in a subset of acute MS lesions: a serial multiparametric MRI study","volume":"33","author":"Eisele","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-007-0754-x","article-title":"MAGNIMS network. MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: a review of reported findings","volume":"255","author":"Seewann","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0180","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1007\/s00415-013-6918-y","article-title":"Atypical idiopathic inflammatory de-myelinating lesions: prognostic implications and relation to multiple sclerosis","volume":"260","author":"Wallner-Blazek","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune as-trocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International panel for NMO diagnosis. International consensus diagnostic criteria for neuromyelitis optica spec-trum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0200","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ene.12898","article-title":"Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands","volume":"23","author":"van Pelt","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0205","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1177\/0883073812455104","article-title":"Acute disseminated encephalomyelitis","volume":"27","author":"Alper","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-2007-1019130","article-title":"Acute disseminated encephalomyelitis: current understanding and controversies","volume":"28","author":"Young","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0215","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archneur.1986.00520060042015","article-title":"Multiple sclerosis. The problem of incorrect diagnosis","volume":"43","author":"Rudick","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","article-title":"Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms","volume":"134","author":"van der Knaap","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0225","first-page":"321","article-title":"Hyperintense punctiform images in the white matter: a diagnostic approach","volume":"54","author":"Martorell","year":"2012","journal-title":"Radiolog\u00eda"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/WNL.44.4.591","article-title":"Susac\u2019s syndrome: the triad of microangiopathy of the brain and retina with hearing loss in young women","volume":"44","author":"Susac","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0235","series-title":"Clinical Neuroradiology","first-page":"167","article-title":"Small vessel disease - imaging and clinical aspects","author":"J\u00e4ger","year":"2019"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0240","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0245","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.291.4.427","article-title":"Migraine as a risk factor for subclinical brain lesions","volume":"291","author":"Kruit","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0250","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(09)70127-9","article-title":"CADASIL","volume":"8","author":"Chabriat","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0255","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1148\/rg.274065722","article-title":"Virchow-Robin spaces at MR imaging","volume":"27","author":"Kwee","year":"2007","journal-title":"RadioGraphics"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0260","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/STROKEAHA.117.016990","article-title":"Diagnosis of cerebral amyloid angiopathy: evolution of the Boston criteria","volume":"49","author":"Greenberg","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1148\/radiol.2018170803","article-title":"Cerebral microbleeds: imaging and clinical significance","volume":"287","author":"Haller","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0270","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00234-019-02335-5","article-title":"Brain miliary enhancement","volume":"62","author":"Bot","year":"2020","journal-title":"Neuroradiology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1756285609347123","article-title":"Diagnosis and treatment of cerebral vasculitis","volume":"3","author":"Berlit","year":"2010","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0285","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00281-009-0183-2","article-title":"Central nervous system vasculitis","volume":"31","author":"Scolding","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0290","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1474-4422(04)00805-1","article-title":"Neurosarcoidosis: a clinical dilemma","volume":"3","author":"Hoitsma","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0295","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00062-019-00837-6","article-title":"CNS infections in immunoincompetent patients. Neuroradiological and clinical features","volume":"30","author":"Weidauer","year":"2020","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0300","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1212\/WNL.0000000000002586","article-title":"Punctate pattern - a promising imaging marker for the diagnosis of natalizumab-associated PML","volume":"86","author":"Hodel","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0305","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/WCO.0000000000000099","article-title":"Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI","volume":"27","author":"Wattjes","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0310","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3174\/ajnr.A5086","article-title":"Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis","volume":"38","author":"Kelley","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0315","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(06)70572-5","article-title":"MRI and the diagnosis of multiple sclerosis: expanding theconcept of \u201cno better explanation\u201d","volume":"5","author":"Charil","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0320","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrneurol.2018.14","article-title":"The current role of MRI in differentiating multiple sclerosis from its imaging mimics","volume":"14","author":"Geraldes","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0325","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ana.25463","article-title":"Silent progression in disease activity\u2013free relapsing multiple sclerosis","volume":"85","author":"University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1148\/radiol.09090814","article-title":"Improved detection of active multiple sclerosis lesions: 3D subtraction imaging","volume":"255","author":"Moraal","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0335","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1055\/a-1167-8402","article-title":"AI in radiology: where are we today in multiple sclerosis imaging?","volume":"192","author":"Eichinger","year":"2020","journal-title":"Fortschr R\u00f6ntgenstr"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0340","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41582-020-0314-x","article-title":"MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice","volume":"16","author":"Sastre-Garriga","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0345","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/jnnp-2020-324534","article-title":"Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications","volume":"92","author":"Wijburg","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0350","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ana.23676","article-title":"Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"72","author":"Yousry","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0355","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0360","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jnnp-2018-318261","article-title":"Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort","volume":"90","author":"Wijburg","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0365","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/acn3.114","article-title":"Outcome and survival of asymptomatic PML in natalizumab-treated MS patients","volume":"1","author":"Dong-Si","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0370","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-pathol-020712-164018","article-title":"Progressive multifocal leukoencephalopathy: why grey and white matter","volume":"8","author":"Gheuens","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0375","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/01.wnl.0000284601.54436.e4","article-title":"Cortical demyelination in PML and MS - similarities and differences","volume":"70","author":"Moll","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clinimag.2021.05.025_bb0380","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1212\/WNL.0b013e3182735cb3","article-title":"Tumefactive multiple sclerosis lesions under fingolimod treatment","volume":"79","author":"Visser","year":"2012","journal-title":"Neurology"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089970712100231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089970712100231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:47:33Z","timestamp":1760269653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089970712100231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":76,"alternative-id":["S089970712100231X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2021.05.025","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic approach in multiple sclerosis with MRI: an update","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2021.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}